Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire
- PMID: 15261563
- DOI: 10.1016/j.jns.2004.04.022
Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire
Abstract
Immunosuppressive treatment is a current practice in MS therapy. Mitoxantrone has gained largest acceptance. Differences in clinical indications of mitoxantrone, cyclophosphamide, azathioprine and methotrexate are described.
Copyright 2004 Elsevier B.V.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical